UBS Group
TSVT

UBS Group’s 2seventy bio TSVT Stock Holding History

UBS Group’s Portfolio TSVT Stock Details TSVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-243,434
Closed -$1.2M – 10834
2025
Q1 		$1.2M Buy
243,434
+18,845
+8% +$59.9K ﹤0.01% 5126
2024
Q4 		$660K Buy
224,589
+201,043
+854% +$825K ﹤0.01% 5651
2024
Q3 		$111K Buy
23,546
+8,202
+53% +$37K ﹤0.01% 6278
2024
Q2 		$59.1K Sell
15,344
-38,020
-71% -$171K ﹤0.01% 6561
2024
Q1 		$285K Sell
53,364
-17,520
-25% -$82.4K ﹤0.01% 5605
2023
Q4 		$303K Buy
70,884
+37,457
+112% +$115K ﹤0.01% 5489
2023
Q3 		$131K Sell
33,427
-49,005
-59% -$321K ﹤0.01% 5661
2023
Q2 		$834K Sell
82,432
-108,344
-57% -$1.15M ﹤0.01% 4400
2023
Q1 		$1.95M Buy
190,776
+97,928
+105% +$1.12M ﹤0.01% 3468
2022
Q4 		$870K Buy
92,848
+74,961
+419% +$1.06M ﹤0.01% 4207
2022
Q3 		$261K Buy
17,887
+3,240
+22% +$48.1K ﹤0.01% 4870
2022
Q2 		$194K Sell
14,647
-137,664
-90% -$1.88M ﹤0.01% 4942
2022
Q1 		$2.6M Buy
152,311
+92,364
+154% +$1.57M ﹤0.01% 3183
2021
Q4 		$1.54M Buy
+59,947
New +$1.87M ﹤0.01% 3985

Other funds holding TSVT

N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

UBS Group's TSVT Position: Q2 2025 in Review

UBS Group sold out of 2seventy bio (TSVT) in Q2 2025, closing a stake of 243,434 shares — an estimated $1.2M sold.

UBS Group first reported a position in TSVT in Q4 2021 and held it in 14 quarters. The position peaked at $2.6M in Q1 2022. 2 funds tracked by Wall St. Rank hold TSVT as of Q2 2025.

  • UBS Group reported no remaining 2seventy bio position as of Q2 2025 after selling out during the quarter.
  • UBS Group sold 243,434 2seventy bio shares in Q2 2025, an estimated $1.2M.
  • UBS Group first reported a position in 2seventy bio in Q4 2021 and held it in 14 quarters.
  • UBS Group's 2seventy bio position peaked at $2.6M in Q1 2022.
  • 2 funds tracked by Wall St. Rank held 2seventy bio as of Q2 2025.

Based on UBS Group's 13F filing for Q2 2025, filed 14 Aug 2025.